Date | Wednesday, May 11, 2022 |
Venue | Flores Ballroom Hotel Borobudur Lapangan Banteng St Central Jakarta |
Time | 10:00 (GMT+7) |
Agenda | - Approval of the company's Annual Report including the Board of Commissioners Oversight Report of the financial year 2021, and Ratification of the company's Consolidated Financial Statements, including the Report on the Implementation of the Social and Environmental Responsibility Program 2021, and to release and discharge of all responsibilities (volledig acquit et de charge) to all Board members for the management and supervision carried out in the financial year 2021.
- Determination on the use of the company net profit of the financial year 2021.
- Determination of Remuneration (Salary/Honorarium, Facilities and Allowances) in 2022 and Tantiem of financial year 2021 for Board of Directors and Board of Commissioners.
- Election of a Public Accountant Firm to audit the company's Consolidated Financial Report and Micro and Small Business Funding Program (PUMK) of the financial year 2022.
- Amendment to the company's Articles of Association.
- Enforcement of the Regulation of the Minister of SOEs of the Republic of Indonesia
- Change of the company management composition.
|
DH/W
KAEF - PT. Kimia Farma Tbk
Rp 705
+5 (+1,00%)